# NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
> **ANDA202086** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2015-04-01
## Drug
- **FDA Application Number:** ANDA202086
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
- **Generic name:** NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
- **Active ingredients:** ETHINYL ESTRADIOL; NORETHINDRONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **Manufacturer:** Mylan Pharmaceuticals Inc.
- **First approval:** 2015-04-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202086)
---
*AI Analytics · CC0 1.0*